Linus Health Closes $55 Million Series B Funding Round, Will Expand Its Cognitive Screening Technology For Earlier Detection Of Alzheimer’s Disease

Digital health company Linus Health raised $55 million from its existing investors in a Series B funding round. The funds will enable Linus Health to grow its team and accelerate development of its platform to address the need for cognitive screenings and insights to detect Alzheimer's disease. The platform is used as an accessible, noninvasive, and time-efficient method to assess cognitive health, including pre-symptomatic detection of cognitive impairment due to dementia with the goal of optimizing intervention outcomes and advancing research capabilities.

The Linus platform has been tested in several studies. Researchers have used the Linus platform . . .